CDN

I wish..

Development of low cost rapid diagnostic tools for early stage cancer must be the greatest humanitarian challenge facing biosensor technology - and
one which has the potential for the greatest commercial return, significantly larger than the market for glucose sensors. #cancerdiagnostics

Organised by:

Return to Sensor100

“We spend most of our money in treating, rather than investing in diagnostics to know what we’re treating”

Professor Lord Ara Darzi, Imperial College London
Kings Fund report: The Future is Now (2015)

tick
Are you developing biosensors for cancer diagnosis?
tick
Do you think early diagnosis needs more recognition?
tick
Would it help to know who else is working on this?
tick
Do we need better early stage diagnostic tools?
tick
Can improved diagnosis enhance cancer therapy?
tick
Would you like to help shape diagnosis research direction globally?

If you identify with any or all of these questions, join the
Cancer Diagnosis Network
- on open innovation platform to facilitate and promote technology for the early stage diagnosis of cancer

It is envisioned that the network will be supported by:

Annual Membership Fees

Individuals & Pre-revenue companies
£100
Charities, SMEs, & universities
£250
Companies
£1000

Note: 20% VAT will be added to all fees

 


Your privacy is important to us. We will never give, sell or otherwise transfer your contatct details to a third party without your prior permission.